US$ 22.00
fda announcement semaglutide A big win for Wegovy: Weight loss drug first in history to gain approval for reducing heart risks π¨ FDA Ends Semaglutide Shortage
Description
Many find that scheduling meals rather than relying on hunger prevents inadvertent undereating that could compromise muscle mass or energy levels
13,14 Table 1

Arterioscler Thromb Vasc Biol
Summary: GLP-1 medications slow gut motility and gastric emptying, leading to harder stools and constipation, which can be managed through increased dietary fibre, adequate hydration, regular physical activity, and appropriate laxative use when necessary
Chen X et al
